Tibet Cheezheng Tibetan Medicine Co., Ltd.

SZSE:002287.SZ

24.08 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 2,010.3132,044.7891,770.4861,476.2141,402.6771,213.2091,053.151968.354994.728950.106969.467934.275789.225523.645469.298413.48339.273267.916
Cost of Revenue 382.417324.14265.342206.733180.298147.957133.124150.032201.047250.052356.379436.587359.252135.92697.24870.63463.27956.75
Gross Profit 1,627.8961,720.651,505.1431,269.4811,222.3791,065.253920.027818.322793.68700.054613.087497.688429.973387.719372.05342.847275.995211.166
Gross Profit Ratio 0.810.8410.850.860.8710.8780.8740.8450.7980.7370.6320.5330.5450.740.7930.8290.8130.788
Reseach & Development Expenses 50.53955.09470.82360.32455.54936.81425.76328.89530.54531.26225.44717.296000000
General & Administrative Expenses 55.29447.67443.23633.84455.18521.23618.00122.97926.9923.49129.67824.06352.76349.91439.02133.9530.6516.988
Selling & Marketing Expenses 977.775938.168842.709714.903699.718629.986517.507462.967410.079353.435281.705217.779183.952186.481184.808177.864151.073100.51
SG&A 1,111.921985.841885.945748.747754.903651.222535.508485.947437.069376.927311.383241.842236.715236.395223.83211.814181.723117.498
Other Expenses 0.84477.98150.51537.52843.493-3.7142.36938.46718.30753.29538.43515.8517.67619.88513.3523.7548.7527.199
Operating Expenses 1,161.6161,118.9161,007.283846.599853.946744.523605.585566.603542.715465.196388.882298.451245.754243.482231.773218.189187.373121.874
Operating Income 466.28521.541790.206457.279401.529354.046321.663275.315273.086232.912219.711207.009195.304154.103149.786133.437109.07897.278
Operating Income Ratio 0.2320.2550.4460.310.2860.2920.3050.2840.2750.2450.2270.2220.2470.2940.3190.3230.3220.363
Total Other Income Expenses Net 176.245-2.339-2.292-10.577-0.2729.6039.5962.04340.40551.20633.69523.6118.72429.69122.38912.48128.93115.13
Income Before Tax 642.525519.202787.914446.702401.259350.333324.032313.763291.371286.064257.9222.847202.943173.928162.666137.138117.553104.422
Income Before Tax Ratio 0.320.2540.4450.3030.2860.2890.3080.3240.2930.3010.2660.2390.2570.3320.3470.3320.3460.39
Income Tax Expense 65.23549.69477.08840.78536.86932.89123.2625.97730.01450.59546.73535.04732.2933.3381.4821.1861.6220.071
Net Income 581.199472.542715.876403.961364.254318.767300.842289.862264.911237.534213.373190.179170.718170.461160.812135.795115.84105.95
Net Income Ratio 0.2890.2310.4040.2740.260.2630.2860.2990.2660.250.220.2040.2160.3260.3430.3280.3410.395
EPS 1.10.891.350.760.690.60.570.550.50.450.410.360.320.320.320.280.252.04
EPS Diluted 1.10.891.350.760.690.60.570.550.50.450.410.360.320.320.320.280.252.04
EBITDA 562.052665.432901.244510.35435.33380.446358.358350.055330.668268.233264.096217.752196.401183.418151.008146.314128.46495.592
EBITDA Ratio 0.280.3250.5090.3460.310.3140.340.3610.3320.2820.2720.2330.2490.350.3220.3540.3790.357